The Pharmacologic Management of Cardiac Arrest

Card Electrophysiol Clin. 2026 Dec;18(4):471-480. doi: 10.1016/j.ccep.2026.08.006.ABSTRACTThe effectiveness of pharmacologic management of cardiac arrest patients is widely debated; however, several studies published in the past 5 years have begun to clarify some of these issues. This article covers

A Amandeep Singh

Defibrillation in the Cardiac Arrest Patient

Card Electrophysiol Clin. 2026 Dec;18(4):461-470. doi: 10.1016/j.ccep.2026.08.005.ABSTRACTDefibrillation is one of the few interventions known to favorably impact survival in cardiac arrest. In witnessed arrest, survival improves with defibrillation as early as possible, whereas it may improve outco

A Andrea Dreyfuss

Management of Patients After Cardiac Arrest

Card Electrophysiol Clin. 2026 Dec;18(4):449-460. doi: 10.1016/j.ccep.2026.08.004.ABSTRACTCardiac arrest remains a significant cause of morbidity and mortality, although contemporary care now enables potential survival with good neurologic outcome. The core acute management goals for survivors of ca

D Damien Smith

Perioperative Care of Heart Failure, Arrhythmias, and Valvular Heart Disease

Card Electrophysiol Clin. 2026 Dec;18(4):439-447. doi: 10.1016/j.ccep.2026.08.003.ABSTRACTFrequently, the question of whether or not a patient is stable for surgery boils down to the question, "Does this patient need a preoperative stress test?" However, coronary artery disease and ischemic heart di

A Avital Y O'Glasser

Arrhythmias in Adult Congenital Heart Disease Heart Failure

Card Electrophysiol Clin. 2026 Dec;18(4):425-438. doi: 10.1016/j.ccep.2026.08.002.ABSTRACTHeart failure and arrhythmias represent 2 major causes of mortality and morbidity in adults with congenital heart disease. Arrhythmias and heart failure are interdependent, and one may exacerbate the other. Tre

A Anudeep K Dodeja

Cardiac Arrhythmias and Sleep Disorders

Card Electrophysiol Clin. 2026 Dec;18(4):415-424. doi: 10.1016/j.ccep.2026.08.009.ABSTRACTSleep disordered breathing (SDB), periodic limb movements of sleep, insomnia, sleep curtailment, and sleep architectural changes are associated with cardiac arrhythmias in community-based and clinical cohort st

C Catherine M Heinzinger

Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy

Card Electrophysiol Clin. 2026 Dec;18(4):397-414. doi: 10.1016/j.ccep.2026.08.007.ABSTRACTThis review discusses the range of device therapy for ischemic cardiomyopathy (ICM). This article will review the primary data supporting guideline indications for cardiac implantable electronic devices in pati

Y Yash Kamani

Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy

Card Electrophysiol Clin. 2026 Dec;18(4):383-396. doi: 10.1016/j.ccep.2026.08.008.ABSTRACTAtrial and ventricular arrhythmias are highly comorbid with ischemic cardiomyopathy (ICM) and are associated with worsening symptoms, morbidity, and mortality. This review will discuss the pathophysiology, eval

A Abhinav Sehgal

Modulating Perioperative Ventricular Excitability

Card Electrophysiol Clin. 2026 Dec;18(4):373-381. doi: 10.1016/j.ccep.2026.08.001.ABSTRACTCardiac arrhythmias are associated with significant morbidity and mortality. Ventricular arrhythmogenesis is a dynamic interplay among an arrhythmogenic substrate, myocardial electrophysiologic properties, modi

K Kimberly Howard-Quijano

Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia

Pharmacoepidemiol Drug Saf. 2026 Nov;35(11):e70503. doi: 10.1002/pds.70503.ABSTRACTAIM: To describe Australian trends in JAKi uptake, where there are no restrictions on the sequence of their use in clinical practice.METHODS: We included all people aged 18 years and over initiating a JAKi between 1 O

C Claire T Deakin